EVA Q P

Description

IBS is associated with constipation, diarrhea, or alternating bowel patterns with abdominal pain, bloating, and flatulence. The bulking agent Ispaghula relieves both constipation as well as diarrhea. Probiotics restrict pathogenic bacteria while prebiotics promote beneficial bacteria, making the formulation effective for symptomatic management of all types of IBS.

Indications

• IBS-C, IBS-D, IBS-M (Mixed)
• Constipation
• Antibiotic Associated Diarrhea

Composition

• Ispaghula Husk – 3.5 gm
• L. Acidophilus – 1500 Millions
• L. Plantarum – 500 Millions
• Bifidobacterium Longum – 500 Millions
• Bifidobacterium Infantis – 500 Millions
• Fructooligosaccharides – 50 mg

Dosage

IBS: 2 spoons BID (each spoon = 5 grams)

Constipation: 1–2 spoons per day

“For Healthcare Professionals & Business Partners Only”

EVA Q Syrup

Description

Lactitol monohydrate syrup; minimally absorbed & not hydrolysed by gastrointestinal disaccharidases. Gentle and reliable bowel regulation, safe for long-term use, suitable for children and diabetic patients.

Indications

• Treatment of constipation
• Prevention and treatment of hepatic encephalopathy

Composition

Each 15 ml contains:

• Lactitol U.S.P. – 10 gm
• Benzoic Acid I.P. – 0.0225 gm

Dosage & Administration

Constipation

Adults: 15–30 ml per day

Paediatric (2 to 6 years): 10 ml per day

Above 6 years: 10–15 ml per day

Infants/breastfed babies: 5 ml per day

Hepatic Encephalopathy

Prevention: 30 ml once daily in evening

Treatment (Acute phase): 45–90 ml/day divided into 3 doses with meals

Side Effects

Abdominal distension or cramps and flatulence; occasionally diarrhea & anal pruritus.

Contraindications

Appendicitis, intestinal obstruction, suspected organic GIT lesion, unexplained abdominal pain/bleeding, or hypersensitivity to formulation.

Presentation

Available in 100 ml, 200 ml, and 450 ml bottles.

“For Healthcare Professionals & Business Partners Only”